Related Experiment Video
Updated: Aug 16, 2025

06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.3K
Evaluating Mobius3D Dose Calculation Accuracy for Small-Field Flattening- Filter-Free Photon Beams
Changhwan Kim1, Jihun Kim2, Young Kyu Lee3
1Department of Radiation Oncology, Yonsei Cancer Center, 37991Yonsei University College of Medicine, Seoul, South Korea.
Technology in Cancer Research & Treatment
|December 26, 2022
Summary
Mobius3D shows dose calculation inaccuracies for small-field, flattening-filter-free x-rays used in stereotactic body radiation therapy (SBRT). Improvements in beam and multileaf collimator (MLC) modeling are needed for reliable clinical use.
Area of Science:
- Medical Physics
- Radiation Oncology
- Radiotherapy Dosimetry
Background:
- Flattening-filter-free (FFF) x-ray beams are increasingly used in stereotactic body radiation therapy (SBRT) due to their efficiency.
- Accurate dose calculation is critical for SBRT treatment planning and quality assurance (QA).
- Mobius3D is a treatment planning system used for dose calculation and QA.
Purpose of the Study:
- To evaluate the dose calculation accuracy of Mobius3D for small-field FFF x-ray beams.
- To assess the impact of beam and multileaf collimator (MLC) modeling on Mobius3D's accuracy in SBRT applications.
- To identify specific conditions where Mobius3D's accuracy is compromised for FFF beams.
Main Methods:
- Commissioning of Mobius3D for unflattened 6 MV and 10 MV FFF beams, including beam model adjustment and dosimetric leaf gap (DLG) optimization.
- Experimental evaluation using artificial plans to assess small-field modeling accuracy.
- Retrospective analysis of SBRT patient plans to evaluate dose calculation accuracy against measured data.
Main Results:
- Significant dose calculation differences were observed for fields >5 cm off-axis and <1 cm field size.
- Maximum absolute errors of 9.96% (6 MV) and 9.07% (10 MV) occurred at 1 cm field size in artificial plans.
- For patient plans, mean gamma passing rates (3%/3 mm) were 63.6% (6 MV) and 82.6% (10 MV), with average dose differences up to -19.9% (6 MV) and -10.1% (10 MV).
Conclusions:
- Mobius3D exhibits dose calculation uncertainties for small-field FFF photon beams.
- Current beam and MLC modeling in Mobius3D requires improvement for reliable SBRT pretreatment QA.
- Further development is necessary to enhance Mobius3D's accuracy in clinical SBRT applications.

